OpenAlex
PricingAboutJobs
Log inGet started
Work

Glucose lowering and cardiovascular disease: what do we know and what should we do?

HTML

Year: 2010
Type: article
Source: European Journal of Cardiovascular Prevention & Rehabilitation
DOI: 10.1097/01.hjr.0000368194.32356.5f
Authors: Alice Y.Y. Cheng, Lawrence A. Leiter
Institutions: St. Michael's Hospital, University of Toronto, Keenan Research Centre for Biomedical Science
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: glycemic control, type 2 diabetes, cardiovascular disease, tight glycemic control, HbA1c targets, hypoglycemia, diabetic nephropathy, microvascular complications, macrovascular outcomes, UKPDS, diabetes duration, personalized treatment
SDG: Good health and well-being

Open Access status: closed

Funders: Eli Lilly and Company, AstraZeneca, GlaxoSmithKline, Sanofi, Novo Nordisk, Servier
OpenAlex ID: W2099719247
FWCI: 1.247
Cites: 21
Cited by: 16
Related to: 8
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security